SMARCB1 and bladder transitional cell carcinoma: Further, we categorized BLCA tumors into six different groups based on the presence of SMARCB1 genomic alterations (shallow/deep deletions, diploid, gain, and amplification) along with SMARCB1 mRNA expression levels.